Financhill
Sell
21

MASI Quote, Financials, Valuation and Earnings

Last price:
$133.46
Seasonality move :
4.98%
Day range:
$133.21 - $134.81
52-week range:
$131.47 - $194.88
Dividend yield:
0%
P/E ratio:
116.80x
P/S ratio:
4.21x
P/B ratio:
8.84x
Volume:
257.2K
Avg. volume:
778.4K
1-year change:
-20.81%
Market cap:
$7.2B
Revenue:
$2.1B
EPS (TTM):
-$10.61

MASI Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Masimo Corp. shares anticipate an average target of $183.75, ranging from a low estimate of $162.00 to a high estimate of $210.00. This average target implies a growth of 37.87% compared to the current stock price of $133.28.

Consensus Price Target

$183.75

Highest Price Target

$210.00

Lowest Price Target

$162.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 4 4

Hold 2 2 3

Sell 0 0 0
Consensus Buy Buy Buy

MASI Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock